Rein Therapeutics
RNTX
$1.70
Share price
0.00%
Change (1 day)
-72.58%
Change (1 year)
Categories
Revenue for Rein Therapeutics (RNTX)
Revenue in 2024 (TTM): N/A
In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Rein Therapeutics from 2016 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2024 (TTM)  | N/A | |
| 2023 | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A |